Metraipolis › archive › dc_42e532ac14d7
MEK1 as a Synthetic Lethal Target with Cabozantinib in Renal Cell Carcinoma: Insights from CRISPR/Cas9 Screening — Europe PMC PMID:42510829
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42510829
- DOI
- 10.3390/genes17070789
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T07:59:26.592Z
- SHA-256 of the archived text
6f84751aa90c2e79f6feed61258607ca0aa7421ff49bbf7be78ee3e1396480f0- Stable URL of this page
https://metraipolis.com/documento/dc_42e532ac14d7
How to cite
MEK1 as a Synthetic Lethal Target with Cabozantinib in Renal Cell Carcinoma: Insights from CRISPR/Cas9 Screening — Europe PMC PMID:42510829 — Europe PMC (en), https://europepmc.org/article/MED/42510829 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_42e532ac14d7 (Metraipolis archive dc_42e532ac14d7, sha256 6f84751aa90c2e79f6feed61258607ca0aa7421ff49bbf7be78ee3e1396480f0)
BibTeX
@misc{dc42e532ac14d7,
title = {MEK1 as a Synthetic Lethal Target with Cabozantinib in Renal Cell Carcinoma: Insights from CRISPR/Cas9 Screening — Europe PMC PMID:42510829},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42510829},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_42e532ac14d7; sha256 6f84751aa90c2e79f6feed61258607ca0aa7421ff49bbf7be78ee3e1396480f0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42510829. Agents can read the archived copy with the MCP tool read_document.